Homocysteine: A Metabolic Marker in a Whole-Body Context

Protein foods such as meat, eggs, dairy products and fish contain the essential amino acid methionine. Once it enters the body, methionine takes part in an important metabolic cycle. Homocysteine is an intermediate naturally produced in this cycle. It is therefore not simply a “toxin”. What matters is whether the body can metabolise it appropriately after it is formed.

How is homocysteine produced?

Methionine is first converted into SAM, or S-adenosylmethionine. SAM can be thought of as a “methyl-group carrier”: it provides methyl groups for reactions involving DNA, proteins, lipids and many other molecules. [1]

After donating a methyl group, SAM becomes SAH, or S-adenosylhomocysteine, which is then metabolised to form homocysteine.

Methionine → SAM → SAH → Homocysteine

This is a normal pathway operating every day. The important question is not whether homocysteine is produced, but whether its production exceeds the body’s capacity to metabolise it.

How does the body handle homocysteine?

Homocysteine has two principal metabolic routes.

1. Remethylation: recycling it into methionine

The body can provide another methyl group to homocysteine, converting it back into methionine for another round of the cycle. This recycling route has two main systems.

The first depends on folate and vitamin B12. Folate is converted through several steps into 5-methyltetrahydrofolate, which supplies the methyl group. Vitamin B12 participates in the final transfer. Vitamin B2 also contributes: FAD, derived from B2, is an important cofactor for the MTHFR enzyme.

Folate supplies the methyl-group source, B2 supports MTHFR function, and B12 participates in methyl-group transfer.

The second system operates mainly in the liver and kidneys and uses betaine. Through the BHMT enzyme, betaine donates a methyl group to homocysteine, helping convert it into methionine. Betaine comes partly from food and can also be produced from choline. [1]

Choline, betaine and homocysteine metabolism are therefore directly connected.

2. Transsulfuration: forming cysteine

Some homocysteine enters the transsulfuration pathway rather than being recycled into methionine. With the relevant enzymes and PLP, the active form of vitamin B6, it is converted as follows: [1]

Homocysteine → Cystathionine → Cysteine

Cysteine can then contribute to glutathione synthesis. Glutathione is an important intracellular antioxidant involved in maintaining redox balance and protecting cells.

Homocysteine is thus not merely a waste product. It sits at an important junction connecting the methionine cycle, methylation, transsulfuration and glutathione metabolism.

Why do elevated levels deserve attention?

Many observational studies have associated higher homocysteine levels with increased cardiovascular and cerebrovascular risk. Proposed mechanisms include:

Increased oxidative stress: persistently elevated homocysteine may promote reactive oxygen species and impair vascular endothelial function.

Reduced nitric oxide availability: nitric oxide acts as a relaxation signal within blood vessels. Reduced availability may impair vessel dilation and endothelial function.

Effects on inflammation, blood vessels and coagulation: higher levels may also be linked to lipoprotein oxidation, vascular smooth-muscle changes, inflammation and altered balance between coagulation and anticoagulation.

A 2002 BMJ meta-analysis reported that, in prospective studies, each 5 µmol/L higher homocysteine concentration was associated with an odds ratio of 1.32 for ischaemic heart disease and 1.59 for stroke. These are relative odds estimates, not absolute increases in an individual’s probability of disease. [2]

An association with disease risk does not mean that lowering the number alone will necessarily prevent a heart attack or stroke.

Later randomised trials found that folate, B12 and B6 can lower homocysteine but have not consistently shown a reduction in myocardial infarction or mortality. A Cochrane review found a small reduction in stroke outcomes in some comparisons; this does not establish a universal benefit for everyone. [3]

Homocysteine is a useful metabolic and risk marker to consider, but it should not be interpreted in isolation from the person’s overall situation.

Cognition and pregnancy

Observational studies have linked higher homocysteine to cognitive decline. A longitudinal study of adults aged 65–79 who were free of dementia at baseline found associations between higher homocysteine and poorer subsequent global cognition, memory, executive function and language performance. [4]

However, lowering homocysteine does not necessarily improve cognitive decline that is already present.

Higher maternal homocysteine has also been associated with preeclampsia, preterm birth, fetal loss, low birth weight and being small for gestational age. These findings suggest possible value as a risk marker; they do not by themselves establish a direct causal relationship. [5]

What counts as high?

Many laboratories use an approximate adult total homocysteine reference interval of 5–15 µmol/L. A rough classification is: [6]

15–30 µmol/L: mildly elevated.
30–100 µmol/L: moderately elevated.
Above 100 µmol/L: markedly elevated.

Classification terms and boundaries vary; use the reporting laboratory’s reference interval. Some studies and nutritional assessments use around 10 µmol/L as a stricter threshold, and some describe values below 10 as relatively desirable.

Below 10 µmol/L is not a universally agreed “optimal” target across medical guidelines.

Interpretation should consider age, nutritional status, kidney and thyroid function, medicines and overall health. Markedly elevated results require medical assessment rather than self-treatment.

Why might homocysteine rise?

Elevated homocysteine often has more than one contributing factor.

Low folate: folate is an important methyl-group source for remethylation. Insufficient folate may reduce the efficiency of recycling homocysteine into methionine.

Low vitamin B12: B12 participates directly in methyl-group transfer; deficiency is an important cause of elevated homocysteine.

Low vitamin B2: B2-derived FAD is a cofactor for MTHFR. Inadequate B2 status may affect folate metabolism and remethylation.

Low vitamin B6: B6 supports transsulfuration. Inadequacy can impair metabolism towards cysteine.

Folate, B12, B2 and B6 therefore contribute at different points in the pathway.

What does MTHFR mean?

MTHFR is an enzyme in folate metabolism. It converts 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate, an important methyl-group source for converting homocysteine back into methionine.

A common genetic variant is called C677T. Its genotypes are usually described as:

CC: relatively normal enzyme activity.
CT: somewhat reduced activity.
TT: a more pronounced reduction in activity.

The frequency of the TT genotype varies substantially between populations. C677T is a common genetic variant, not a rare “genetic defect”. [7]

People with the TT genotype may be more likely to develop higher homocysteine when folate status is low.

An MTHFR variant does not mean that homocysteine will necessarily be elevated or that “methylation supplements” are automatically needed. [7]

Decisions should return to actual test results and the overall clinical picture.

Other factors to consider

Kidney function: homocysteine is closely related to kidney function and often rises as kidney function declines. Elevated levels are common in chronic kidney disease; nutrition is not the only possible explanation.

Thyroid function: levels are often higher in overt hypothyroidism and may decrease in some patients after thyroid hormone treatment.

Lifestyle: smoking, heavy alcohol use, limited dietary variety and a long-term lack of vegetables or other B-vitamin-rich foods may influence homocysteine metabolism.

Medicines: metformin may lower vitamin B12 levels. Long-term acid-suppressing treatment, including proton pump inhibitors, may reduce absorption of food-bound B12. If deficiency develops, homocysteine metabolism may be affected. Do not stop or change prescribed medicines without discussing this with the prescriber. [8]

An interconnected nutritional network

From a nutritional perspective, homocysteine is not only about folate. The system involves folate, vitamins B2, B12 and B6, choline and betaine.

These nutrients support methyl-group provision and transfer, MTHFR function, transsulfuration and an alternative remethylation route. They form an interconnected metabolic network rather than working in isolation.

From one marker to the whole person

When homocysteine is elevated, it helps to avoid two extremes: taking only folate because the number is high, or attributing every problem to an MTHFR variant.

The more useful question is: Why is this person’s homocysteine elevated?

Consider whether folate and B vitamins are adequate, whether choline and betaine intake is appropriate, and whether genetic factors, kidney or thyroid function, long-term medicines, diet, smoking or alcohol may play a role.

This is what we mean by a holistic perspective. The body is not a collection of unrelated laboratory values. It is an interconnected system, and a change in one marker may be a signal that warrants investigation of the underlying cause.

The next step is individualised health management. Medicine and nutrition describe general patterns, but there is no single fixed plan that suits everyone.

One person may need dietary adjustments; another may need a confirmed B12 or folate deficiency corrected. Someone else may need assessment of thyroid or kidney function, or a review of medicines and lifestyle with their clinician.

The same marker can have different causes. The same problem does not always require the same solution.

Understanding one marker in the context of the whole person, and then choosing an appropriate individual plan, is the purpose of a holistic and individualised approach.